T-cell receptor and uses thereof

Steven Lee

T-cell receptor and uses thereof

Steven Lee (Inventor)

Immunology and Immunotherapy

Research output: Patent

Abstract

The present invention relates to a T-cell receptor comprising: a) an alpha chain comprising an amino acid sequence as set forth in SEQ ID No.1 or a functional equivalent thereof; and/or b) a beta chain comprising an amino acid sequence as set forth in SEQ ID No.2 or a functional equivalent thereof; as well as uses thereof including in the treatment of an EBV+ tumour.

Original language	English
Patent number	WO/2017/085471
IPC	C07K 14/725,A61K 38/17
Priority date	16/11/15
Publication status	Published - 26 May 2017

Cite this

@misc{ed7944bc3d94466481f9500129e81674,

title = "T-cell receptor and uses thereof",

abstract = "The present invention relates to a T-cell receptor comprising: a) an alpha chain comprising an amino acid sequence as set forth in SEQ ID No.1 or a functional equivalent thereof; and/or b) a beta chain comprising an amino acid sequence as set forth in SEQ ID No.2 or a functional equivalent thereof; as well as uses thereof including in the treatment of an EBV+ tumour.",

author = "Steven Lee",

year = "2017",

month = may,

day = "26",

language = "English",

type = "Patent",

note = "WO/2017/085471; C07K 14/725,A61K 38/17",

}

TY - PAT

T1 - T-cell receptor and uses thereof

AU - Lee, Steven

PY - 2017/5/26

Y1 - 2017/5/26

N2 - The present invention relates to a T-cell receptor comprising: a) an alpha chain comprising an amino acid sequence as set forth in SEQ ID No.1 or a functional equivalent thereof; and/or b) a beta chain comprising an amino acid sequence as set forth in SEQ ID No.2 or a functional equivalent thereof; as well as uses thereof including in the treatment of an EBV+ tumour.

AB - The present invention relates to a T-cell receptor comprising: a) an alpha chain comprising an amino acid sequence as set forth in SEQ ID No.1 or a functional equivalent thereof; and/or b) a beta chain comprising an amino acid sequence as set forth in SEQ ID No.2 or a functional equivalent thereof; as well as uses thereof including in the treatment of an EBV+ tumour.

M3 - Patent

M1 - WO/2017/085471

ER -

T-cell receptor and uses thereof

Abstract

Fingerprint

Cite this